Indus Finance (531841)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹21.86 |
| Market Cap | ₹20.65 Cr |
| P/E Ratio | 46.18 |
| ROCE | 8.95% |
| ROE | 2.35% |
| Dividend Yield | 0.97% |
| Profit Growth | -16.33% |
| Debt/Equity | — |
| Sales Growth | -9.27% |
| 52-Week Range | ₹38.94 — ₹115.5 |
| Sector | Finance |
| Book Value | ₹26.76 |
Strengths
- Trades at 0.82 times book value, offering a margin of safety against stated net assets of ₹26.76 per share.
- Small market cap of ₹21 Cr leaves room for value unlocking if underlying assets are genuine.
- Positive book value per share provides a potential cushion despite weak earnings.
- Modest dividend yield of 0.97% indicates some cash distribution to shareholders.
- ROCE of 8.95% is higher than ROE, suggesting operating assets generate some return before leverage effects.
Concerns
- Revenues declined 9.27% and profits fell 16.33%, showing a shrinking business.
- Latest quarter sales of ₹1 Cr and net profit of ₹0 Cr reflect negligible earnings power.
- ROE of only 2.35% means shareholder capital is being deployed with very poor returns.
- Piotroski F-Score of 3/9 signals weak financial health and possible distress.
AI Analysis
At ₹21.86, Indus Finance is a tiny NBFC with a market cap of just ₹21 crore. It immediately catches my eye because it trades at 0.82 times book value, with a book value of ₹26.76 per share. Benjamin Graham taught me to seek a margin of safety, and a price below stated book can provide that—if the book is genuine and earning power eventually shows up. But this is where enthusiasm must pause. The latest quarter tells a sobering story: sales of ₹1 crore and net profit of essentially ₹0 crore. Over the year, sales fell 9.27% and profits fell 16.33%. This is not a wonderful business compounding value; it is a small, shrinking operation. Return on equity is only 2.35%, far below what I'd demand from an NBFC. A Piotroski F-Score of 3 out of 9 reinforces the concern: the financial fundamentals are weak. The dividend yield of 0.97% is negligible, and the price is quoted below the 52-week range, which often signals either a data anomaly or deep distress. At 46 times earnings, the market is still paying a rich multiple for earnings that are barely there. I would not call this a stalwart or a grower. It is an asset play at best. My interest would depend on whether the stated book value is realistic, whether management can stop the decline, and whether capital is being deployed honestly. Until I see a few quarters of positive momentum and improving return metrics, this remains a possible value trap rather than a high-conviction investment. I'd watch, not jump.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer